Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 3
2021 2
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial.
Meattini I, Marrazzo L, Saieva C, Desideri I, Scotti V, Simontacchi G, Bonomo P, Greto D, Mangoni M, Scoccianti S, Lucidi S, Paoletti L, Fambrini M, Bernini M, Sanchez L, Orzalesi L, Nori J, Bianchi S, Pallotta S, Livi L. Meattini I, et al. Among authors: lucidi s. J Clin Oncol. 2020 Dec 10;38(35):4175-4183. doi: 10.1200/JCO.20.00650. Epub 2020 Aug 24. J Clin Oncol. 2020. PMID: 32840419 Clinical Trial.
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review.
Becherini C, Lancia A, Detti B, Lucidi S, Scartoni D, Ingrosso G, Carnevale MG, Roghi M, Bertini N, Orsatti C, Mangoni M, Francolini G, Marani S, Giacomelli I, Loi M, Pergolizzi S, Bonzano E, Aristei C, Livi L. Becherini C, et al. Among authors: lucidi s. Strahlenther Onkol. 2023 Dec;199(12):1173-1190. doi: 10.1007/s00066-023-02097-3. Epub 2023 Jun 22. Strahlenther Onkol. 2023. PMID: 37347290 Free PMC article. Review.
Choline PET/CT in recurrent prostate cancer.
Detti B, Carnevale MG, Lucidi S, Burchini L, Caini S, Orsatti C, Bertini N, Roghi M, di Cataldo V, Fondelli S, Ingrosso G, Francolini G, Scartoni D, Sardaro A, Pisani A, Scoccianti S, Aristei C, Livi L. Detti B, et al. Among authors: lucidi s. Front Oncol. 2023 Mar 21;13:1079808. doi: 10.3389/fonc.2023.1079808. eCollection 2023. Front Oncol. 2023. PMID: 37025599 Free PMC article.
Regorafenib in glioblastoma recurrence: A case report.
Detti B, Scoccianti S, Lucidi S, Maragna V, Teriaca MA, Ganovelli M, Desideri I, Lorenzetti V, Scoccimarro E, Greto D, Livi L. Detti B, et al. Among authors: lucidi s. Cancer Treat Res Commun. 2021;26:100263. doi: 10.1016/j.ctarc.2020.100263. Epub 2020 Dec 10. Cancer Treat Res Commun. 2021. PMID: 33338858 Free article.
Axillary Management in Breast Cancer Patients Undergoing Upfront Surgery: Results from a Nationwide Survey on Behalf of the Clinical Oncology Breast Cancer Group (COBCG) and the Breast Cancer Study Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
De Rose F, Colciago RR, Lucidi S, La Rocca E, Prisco A, Bonzano E, Meduri B, De Santis MC, Dicuonzo S, Pasinetti N, Palumbo I, Meattini I, Franco P. De Rose F, et al. Among authors: lucidi s. Curr Oncol. 2023 Aug 8;30(8):7489-7498. doi: 10.3390/curroncol30080542. Curr Oncol. 2023. PMID: 37623023 Free PMC article.
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719).
Francolini G, Detti B, Di Cataldo V, Garlatti P, Aquilano M, Allegra A, Lucidi S, Cerbai C, Ciccone LP, Salvestrini V, Stocchi G, Guerrieri B, Visani L, Loi M, Desideri I, Mangoni M, Meattini I, Livi L. Francolini G, et al. Among authors: lucidi s. Radiol Med. 2022 Aug;127(8):912-918. doi: 10.1007/s11547-022-01511-7. Epub 2022 Jun 28. Radiol Med. 2022. PMID: 35763249 Free PMC article. Clinical Trial.
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833).
Desideri I, Lucidi S, Francolini G, Meattini I, Ciccone LP, Salvestrini V, Valzano M, Morelli I, Angelini L, Scotti V, Bonomo P, Greto D, Terziani F, Becherini C, Visani L, Livi L. Desideri I, et al. Among authors: lucidi s. Med Oncol. 2022 Jun 6;39(8):113. doi: 10.1007/s12032-022-01723-x. Med Oncol. 2022. PMID: 35666314 Clinical Trial.
13 results